XML Print


1- Medical microbiology , sarahahmed100@uokirkuk.edu.iq
2- Medical Microbiology
3- Plant genetics
Abstract:   (109 Views)

Bachground:Carbapanenems are β-lactam antibiotics that have multiple bactericidal activities. These antibacterial are usually considered to be the last-choice drugs in treating infections with multi-drug resistant Gram-negative bacteria.  Carbapenemase producing organisms (CPOs) are associated with serious health care-associated infections, making the mortality rate higher.

Methods:250 samples were collected with sterile cotton swabs; from wounds and burn wounds patients (140 wound swabs and 110 burn swabs). These swabs were cultured on MacConkey agar and cetrimide agar.  Cultures were incubated at 37°C for 18–24 hrs. The appearance of the colonies was evaluated by colour, shape, and overall morphology. BD Phoenix™ M50 device is used in identifying and making sensitivity test with BD RAPIDEC® CARBA NP assay in detecting carbapenemase enzymes.

Results:27(38.02%) isolates were carbapenemase producing and multi-drug resistance , distributed as following : 12 Carbapenemase producing Pseusomona aeruginosa multi-drug resistance, 9Carbapenemase producing Escherichia coli multi-drug resistance, 5carbapenemase producing Enterobacter cloacae multi-drug resistance and one isolate of Carbapenemase producing Klebsiella pneumoniae multi-drug resistance. The current study reported CP-Pseudomonas aeruginosa and CP-Klebsiella pneumoniae isolates as pathogens with the highest number of antibiotics resistance (resist 15 different antibiotics from seven classes of antibiotics).

Conclusion: In current study ,the carbapenemase producing organisms (CPOs) were highly MDR against most classes of antibiotics due to misuse or overuse of antibiotics,
one of the most urging topics to follow is to recognize and develop modern drugs to combat the carbapenem resistant organisms with multi-drug patterns that are known to cause higher morbidity and mortality among patients globally.
Full-Text [PDF 311 kb]   (30 Downloads)    
Research Article: Original Paper | Subject: bacteriology
Received: 2024/04/22 | Accepted: 2024/04/23

References
1. Dos Santos GS, Solidônio EG, Costa MC, Melo RO, de Souza IF, Silva G, et al. Study of the Enterobacteriaceae Group CESP (Citrobacter, Enterobacter, Serratia, Providencia, Morganella and Hafnia): A Review. The Battle Against Microbial Pathogens: Basic Science, Technological Advances and Educational Programs (A. Méndez-Vilas, Ed.) FORMATEX. 2015:794-805. [View at Publisher] [Google Scholar]
2. Patel G, Bonomo RA. Status report on carbapenemases: challenges and prospects. Expert Rev Anti Infect Ther. 2011;9(5):555-70. [View at Publisher] [DOI] [PMID] [Google Scholar]
3. Hasoon NA, Hamed SL. Molecular characterization of carbapenemase-producing Gram-negative bacteria isolated from clinical specimens in Baghdad. J Pure Appl Microbiol. 2019;13(2):1031-40. [View at Publisher] [DOI] [Google Scholar]
4. Tarashi S, Goudarzi H, Erfanimanesh S, Pormohammad A, Hashemi A. Phenotypic and molecular detection of metallo-beta-lactamase genes among imipenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients with burn injuries. Arch Clin Infect Dis. 2016;11(4):e39036. [View at Publisher] [DOI] [Google Scholar]
5. Nordmann P. Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge. Med Mal Infect. 2014;44(2):51-6. [View at Publisher] [DOI] [PMID] [Google Scholar]
6. Iraz M, Düzgün AÖ, Sandallı C, Doymaz MZ, Akkoyunlu Y, Saral A, et al. Distribution of β-lactamase genes among carbapenem-resistant Klebsiella pneumoniae strains isolated from patients in Turkey. Ann Lab Med. 2015;35(6):595-601. [View at Publisher] [DOI] [PMID]
7. Bush K, Pannell M, Lock JL, Queenan AM, Jorgensen JH, Lee RM, et al. Detection systems for carbapenemase gene identification should include the SME serine carbapenemase. Int J Antimicrob Agents. 2013;41(1):1-4. [View at Publisher] [DOI] [PMID] [Google Scholar]
8. Thomson KS. Extended-spectrum-β-lactamase, AmpC, and carbapenemase issues. J Of Clin Microbiol. 2010;48(4):1019-25. [View at Publisher] [DOI] [PMID] [Google Scholar]
9. Mahrach Y, Mourabit N, Arakrak A, Bakkali M, Laglaoui A. Phenotypic and molecular study of carbapenemase-producing Enterobacteriaceae in a regional hospital in northern Morocco. J Clin Med Sci. 2019;3(1):113. [View at Publisher] [Google Scholar]
10. Hasan SA, Raoof WM, kamal Rachid S. A systematic review: The current status of carbapenem resistance in Iraq. World Bulletin of Public Health. 2022;13:88-94. [View at Publisher] [Google Scholar]
11. Hasan SA, Raoof WM, Ahmed KK. FIRST REPORT OF CO-HARBORING BLEOMYCIN RESISTANCE GENE (bleMBL) AND CARBAPENEMASE RESISTANCE GENE (blaNDM-1) KLEBSIELLA PNEUMONIAE IN IRAQ WITH COMPARISON STUDY AMONG THE SENSITIVITY TEST, THE BD PHOENIX CPO DETECT TEST, AND THE RAPIDEC® CARBA NP TEST. SJLSA. 2024;16(4):208-37. [View at Publisher] [DOI] [Google Scholar]
12. Suay-García B, Pérez-Gracia MT. Present and future of carbapenem-resistant Enterobacteriaceae infections. Advances in clinical immunology, medical microbiology, COVID-19, and big data. 2021:435-56. [View at Publisher] [DOI] [PMID] [Google Scholar]
13. Haji SH, Aka STH, Ali FA. Prevalence and characterisation of carbapenemase encoding genes in multidrug-resistant Gram-negative bacilli. PLoS One. 2021;16(11):e0259005. [View at Publisher] [DOI] [PMID] [Google Scholar]
14. Aurilio C, Sansone P, Barbarisi M, Pota V, Giaccari LG, Coppolino F, et al. Mechanisms of action of carbapenem resistance. Antibiotics. 2022;11(3):421. [View at Publisher] [DOI] [PMID] [Google Scholar]
15. Elshamy AA, Aboshanab KM. A review on bacterial resistance to carbapenems: epidemiology, detection and treatment options. Future science OA. 2020;6(3):FSO438. [View at Publisher] [DOI] [PMID] [Google Scholar]
16. Hasan SA, Abass KS. Prevalence of Gram Negative Bacteria Isolated from Patients with Burn Infection and their Antimicrobial Susceptibility Patterns in Kirkuk City, Iraq. Indian J Public Health Res Dev. 2019;10(8). [View at Publisher] [DOI] [Google Scholar]
17. Ahmed Hasan S, Raheem TF, Abdulla HM. Phenotypic, antibiotyping, and molecular detection of Klebsiella pneumoniae isolates from clinical specimens in Kirkuk, Iraq. Arch Razi Inst. 2021;76(4):1061-7. [View at Publisher] [DOI] [PMID] [Google Scholar]
18. Ahmed Hasan S, Mohammed Bakr M. Bacteriological and molecular detection of Klebsiella oxytoca and its resistance to antibiotics among clinical specimens from Kirkuk, Iraq. Arch Razi Inst. 2022;77(5):1521-5. [View at Publisher] [DOI] [PMID] [Google Scholar]
19. Workneh M, Yee R, Simner PJ. Phenotypic methods for detection of carbapenemase production in carbapenem-resistant organisms: what method should your laboratory choose?.Clin Microbiol Newsl. 2019;41(2):11-22. [View at Publisher] [DOI] [Google Scholar]
20. Hasan SA. Pseudomonas aeruginosa and the multifactorial antibiotic resistance. Eurasian Medical Research Periodical. 2022;11:85-94. [View at Publisher] [Google Scholar]
21. Fakhraddin Raheem T, Ahmed Hasan Ali S. Prevalence and multi-drug resistance patterns of uropathogenic E. coli isolated from women patients in Kirkuk City, Iraq. Iran J Microbio. 2022;16(6):609-14. [View at Publisher] [DOI] [Google Scholar]
22. Sadeghi MR, Ghotaslou R, Akhi MT, Asgharzadeh M, Hasani A. Molecular characterization of extended-spectrum β-lactamase, plasmid-mediated AmpC cephalosporinase and carbapenemase genes among Enterobacteriaceae isolates in five medical centres of East and West Azerbaijan, Iran. J Med Microbiol. 2016;65(11):1322-31. [View at Publisher] [DOI] [PMID] [Google Scholar]
23. Hasan SA, Raoof WM, Ahmed KK. Antibacterial activity of deer musk and Ziziphus spina-christi against carbapebem resis-tant gram negative bacteria isolated from patients with burns and wounds. Regulatory Mechanisms in Biosystems. 2024;15(2):267-78. [View at Publisher] [DOI] [Google Scholar]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2007 All Rights Reserved | Medical Laboratory Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.